Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: A cross-sectional case-control study of 7078 Koreans undergoing health check-ups

Gut

Volumn 57, Issue 10, 2008, Pages 1360-1365

  Chung, S J ^a   Kim, D ^a   Park, M J ^a   Kim, Y S ^a   Kim, J S ^b   Jung, H C ^b   Song, I S ^b  

^a Seoul National University Hospital Healthcare System Gangnam Center   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL RADIOGRAPHY; ADULT; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; OBESITY; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; RISK FACTOR; SUBCUTANEOUS FAT;

ABDOMINAL FAT; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ESOPHAGITIS, PEPTIC; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; RISK FACTORS;

EID: 52649156530     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2007.147090     Document Type: Article

References (51)

1. Yeh C, Hsu CT, Ho AS, et al. Erosive esophagitis and Barrett's esophagus in Taiwan: a higher frequency than expected. Dig Dis Sci 1997;42:702-6.
2. Manabe N, Haruma K, Mihara M, et al. The increasing incidence of reflux esophagitis during the past 20 years in Japan. Gastroenterology 1999;116:A224.
3. Youn YH, Kang YW, Ahn SH, et al. Prevalence alteration of reflux esophagitis in recent years. Korean J Gastrointest Endosc 2001;23:144-8.
4. Chang CS, Poon SK, Lien HC, et al. The incidence of reflux esophagitis among the Chinses. Am J Gastroenterol 1997;92:668-71.
5. Ruhl CE, Everhart JE. Overweight, but not high dietary fat intake, increases risk of gastroesophageal reflux disease hospitalization: the NHANES I Epidemiologic Followup Study. First National Health and Nutrition Examination Survey. Ann Epidemiol 1999;9:424-35.
6. Lee SJ, Song CW, Jeen YT, et al. Prevalence of endoscopic reflux esophagitis among Koreans. J Gastroenterol Hepatol 2001;16:373-6.
7. El-Serag HB, Johanson JF. Risk factors for the severity of erosive esophagitis in Helicobacter pylori-negative patients with gastroesophageal reflux disease. Scand J Gastroenterol 2002;37:899-904.
8. Labenz J, Jaspersen D, Kulig M, et al. Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative. Am J Gastroenterol 2004;99:1652-6.
9. El-Serag HB, Graham DY, Satia JA, et al. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol 2005;100:1243-50.
10. Fujiwara Y, Higuchi K, Shiba M, et al. Differences in clinical characteristics between patients with endoscopy-negative reflux disease and erosive esophagitis in Japan. Am J Gastroenterol 2005;100:754-8.
11. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications.Ann Intern Med 2005;143:199-211.
12. Corley DA, Kubo A. Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Gastroenterol 2006;101:2619-28.
13. El-Serag HB, Ergun GA, Pandolfino J, et al. Obesity increases oesophageal acid exposure. Gut 2007;56:749-55.
14. Kang MS, Park Dl, Oh SY, et al. Abdominal obesity is an independent risk factor for erosive esophagitis in a Korean population. J Gastroenterol Hepatol 2007;22:1656-61.
15. Lagergren J. Body measures in relation to gastro-oesophageal reflux. Gut 2007;56:741-2.
16. El-Serag HB, Tran T, Richardson R, et al. Anthropometric correlates of intragastric pressure. Scand J Gastroenterol 2006;41:887-91.
17. Corley DA, Kubo A, Zhao W. Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms. Gut 2007;56:756-62.
18. Bosello O, Zamboni M. Visceral obesity and metabolic syndrome. Obes Rev 2000;1:47-56.
19. Carr DB, Utzschneider KM, Hull RL, et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004;53:2087-94.
20. Morita T, Tabata S, Mineshita M, et al. The metabolic syndrome is associated with increased risk of colorectal adenoma development: the Self-Defense Forces health study. Asian Pacific J Cancer Prev 2005;6:485-9.
21. Kim JH, Lim YJ, Kim YH, et al. Is metabolic syndrome a risk factor for colorectal adenoma. Cancer Epidemiol Biomarkers Prev 2007;16:1543-6.
22. Watanabe S, Hojo M, Nagahara A. Metabolic syndrome and gastrointestinal diseases. J Gastroenterol 2007;42:267-74.
23. Hoshihara Y. Endoscopic findings of GERD. Nippon Rinsho 2004;62:1459-64.
24. WHO/IASO/IOTF. The Asia-Pacific perspective: redefining obesity and its treatment. Health Communications Australia Pty Ltd 2000. http://www.idi.org.au/obesity_report.htm (accessed 5 June 2008).
25. World Health Organization. Report of a WHO consultation on obesity: prevention and managing, the global epidemic. Geneva: World Health Organization, 1999.
26. Borkan GA, Gerzof SG, Robbins AH, et al. Assessment of abdominal fat content by computed tomography. Am J Clin Nutr 1982;36:172-7.
27. Kvist H, Chowdhury B, Grangard U, et al. Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: Predictive equations. Am J Clin Nutr 1988;48:1351-61.
28. Goodpaster BH. Measuring body fat distribution and content in humans. Curr Opin Clin Nutr Metab Care 2002;5:481-7.
29. Baumgartner RN, Heymsfield SB, Roche AF, et al. Abdominal composition quantified by computed tomography. Am J Clin Nutr 1988;48:936-45.
30. Thaete FL, Colberg SR, Burke T, et al. Reproducibility of computed tomography of visceral adipose tissue area. Int J Obes Relat Metab Disord 1995;19:464-7.
31. Mercer CD, Wren SF, DaCosta LR, et al. Lower esophageal sphincter pressure and gastroesophageal pressure gradients in excessively obese patients. J Med 1987;18:135-46.
32. Sugerman HJ. Increased intra-abdominal pressure in obesity. Int J Obes Relat Metab Disord 1998;22:1138.
33. Wajed SA, Streets CG, Bremner CG, et al. Elevated body mass disrupts the barrier to gastroesophageal reflux. Arch Surg 2001;136:1014-8; discussion 1018-9.
34. Barak N, Ehrenpreis ED, Harrison JR, et al. Gastro-oesophageal reflux disease in obesity: pathophysiological and therapeutic considerations. Obes Rev 2002;3:9-15.
35. Wu JC, Mui LM, Cheung CM, et al. Obesity is associated with increased transient lower esophageal sphincter relaxation. Gastroenterology 2007;132:883-9.
36. Van Thiel DH, Wald A. Evidence refuting a role for increased abdominal pressure in the pathogenesis of the heartburn associated with pregnancy. Am J Obstet Gynecol 1981;140:420-2.
37. Backman L, Granstrom L, Lindahl J, et al. Manometric studies of lower esophageal sphincter in extreme obesity. Acta Chir Scand 1983;149:193-7.
38. Ogorek CP, Cohen S. Gastroesophageal reflux disease: new concepts in pathophysiology. Gastroenterol Clin North Am 1989;18:275-92.
39. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003;112:1821-30.
40. Cnop M, Landchild MJ, Vidal J, et al. The concurrent accumulation of intraabdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartment. Diabetes 2002;51:1005-15.
41. Furukawa N, Iwakiri R, Koyama T, et al. Proportion of reflux esophagitis in 6010 Japanese adults: prospective evaluation by endoscopy. J Gastroenterol 1999;34:441-4.
42. Wong WM, Lam SK, Hui WM, et al. Long-term prospective follow-up of endoscopic oesophagitis in southern Chinese - prevalence and spectrum of the disease. Aliment Pharmacol Ther 2002;16:2037-42.
43. Hongo M, Shoji T. Epidemiology of reflux disease and CLE in East Asia. J Gastroenterol 2003;38(Suppl 15):25-30.
44. Hong SP, Park PW, Hwang SG, et al. Significance of non-erosive minimal esophageal lesions in gastro-esophageal reflux disorder. Korean J Int Med 2004;19:93-8.
45. Nakamura T, Shirakawa K, Masuyama H, et al. Minimal change oesophagitis: a disease with characteristic differences to erosive oesophagitis. Aliment Pharmacol Ther 2005;21:19-26.
46. Kiesslich R, Kanzler S, Vieth M, et al. Minimal change esophagitis: prospective comparison of endoscopic and histological markers between patients with non-erosive reflux disease and normal controls using magnifying endoscopy. Dig Dis 2004;22:221-7.
47. Armstrong D, Bennett JR, Blum AL et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996;111:85-92.
48. Bor S, Mandiracioglu A, Kitapcioglu G, et al. Gatroesophageal reflux disease in a low-income region in Turkey. Am J Gastroenterol 2005;100:759-65.
49. Kjellin A, Ramel S, Rossner S, et al. Gastroesophageal reflux in obese patients is not reduced by weight reduction. Scand J Gastroenterol 1996;31:1047-51.
50. Fraser-Moodie CA, Norton B, Gornall C, et al. Weight loss has an independent beneficial effect on symptoms of gastro-oesophageal reflux in patients who are overweight. Scand J Gastroenterol 1999;34:337- 40.
51. Frezza EE, Ikramuddin S, Gourash W, et al. Symptomatic improvement in gastroesophageal reflux disease (GERD) following laparoscopic Roux-en-Y gastric bypass. Surg Endosc 2002;16:1027-31.